Recognizing Far-Reaching Implications of ACLU Anti-Gene Patent Case, Court Denies Myriad’s Motion to Dismiss

"The widespread use of gene sequence information as the foundation for biomedical research means that resolution of these issues will have far-reaching implications, not only for gene-based health care and the health of millions of women facing the specter of breast cancer, but also for the future course of biomedical research," the NY Southern District Court said in an opinion explaining the reasons for denying Myriad’s motion to dismiss ACLU’s challenge to its patents covering BRCA genes associated with hereditary breast and ovarian cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.